Your session is about to expire
← Back to Search
Vitamin D3 for Heart Attack (TARGET-D Trial)
TARGET-D Trial Summary
This trial will test whether raising vitamin D levels in people who have had a heart attack can reduce the risk of having another heart-related problem.
- Heart Attack
- Death
- Stroke
- Heart Failure
TARGET-D Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTARGET-D Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TARGET-D Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any vacancies open to participants in this experiment?
"Affirmative. Data provided on clinicaltrials.gov confirms that this trial, which was first published on April 3rd 2017, is actively recruiting patients. 890 participants are required from one medical site to complete the study."
What health issues is Vitamin D3 proven to ameliorate?
"Vitamin D3 is the most typical treatment for calcium deficiency, however it can also be efficacious in treating conditions like fracture, spine fracture and post menopausal women."
Has the FDA approved Vitamin D3 for use?
"Given the success of its Phase 4 trial, Vitamin D3 has been conferred a score of 3 in terms of safety."
How many participants have been officially accepted into this clinical trial?
"Yes, the information available on clinicaltrials.gov attests to this trial's ongoing recruitment efforts. It was originally posted in April 2017 and has since been modified as recently as August 2022, with a goal of enrolling 890 patients at 1 site."
Are there any previous works exploring the effects of Vitamin D3?
"Presently, 33 studies are inspecting Vitamin D3 with 14 of these trials in their culminating stage. Of the 155 locations running research on this vitamin, many reside in Boston, Massachusetts."
Share this study with friends
Copy Link
Messenger